These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30125607)

  • 1. Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid.
    Perona M; Thomasz L; Rossich L; Rodriguez C; Pisarev MA; Rosemblit C; Cremaschi GA; Dagrosa MA; Juvenal GJ
    Mol Cell Endocrinol; 2018 Dec; 478():141-150. PubMed ID: 30125607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
    Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ
    Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells.
    Brest P; Lassalle S; Hofman V; Bordone O; Gavric Tanga V; Bonnetaud C; Moreilhon C; Rios G; Santini J; Barbry P; Svanborg C; Mograbi B; Mari B; Hofman P
    Endocr Relat Cancer; 2011 Dec; 18(6):711-9. PubMed ID: 21946411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity.
    Perona M; Ibañez IL; Thomasz L; Villaverde MS; Oglio R; Rosemblit C; Grissi C; Campos-Haedo M; Dagrosa MA; Cremaschi G; Durán HA; Juvenal GJ
    J Endocrinol Invest; 2023 Nov; 46(11):2353-2365. PubMed ID: 37052871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells.
    Li L; Sun Y; Liu J; Wu X; Chen L; Ma L; Wu P
    BMC Biochem; 2015 Jan; 16():2. PubMed ID: 25592494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination.
    Koprinarova M; Botev P; Russev G
    DNA Repair (Amst); 2011 Sep; 10(9):970-7. PubMed ID: 21824827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma.
    Shoji M; Ninomiya I; Makino I; Kinoshita J; Nakamura K; Oyama K; Nakagawara H; Fujita H; Tajima H; Takamura H; Kitagawa H; Fushida S; Harada S; Fujimura T; Ohta T
    Int J Oncol; 2012 Jun; 40(6):2140-6. PubMed ID: 22469995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
    Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
    Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid modulates radiation-enhanced matrix metalloproteinase activity and invasion of breast cancer cells.
    Artacho-Cordón F; Ríos-Arrabal S; Olivares-Urbano MA; Storch K; Dickreuter E; Muñoz-Gámez JA; León J; Calvente I; Torné P; Salinas Mdel M; Cordes N; Núñez MI
    Int J Radiat Biol; 2015; 91(12):946-56. PubMed ID: 26490761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments.
    Harikrishnan KN; Karagiannis TC; Chow MZ; El-Osta A
    Cell Cycle; 2008 Feb; 7(4):468-76. PubMed ID: 18239454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities of epigenetic anti-tumor therapy in in-vitro models].
    Kovalëv RA; Stam TA; Ibatulin FM; Bondarev GN; Filatov MV
    Vopr Onkol; 2012; 58(6):800-7. PubMed ID: 23600307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia.
    Singh V; Bhatia HS; Kumar A; de Oliveira AC; Fiebich BL
    Neuroscience; 2014 Apr; 265():147-57. PubMed ID: 24480366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitors.
    Fujii K; Suzuki N; Jimura N; Idogawa M; Kondo T; Iwatsuki K; Kanekura T
    J Dermatol Sci; 2018 Apr; 90(1):82-89. PubMed ID: 29395577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
    Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
    Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic modifier, valproic acid, enhances radiation sensitivity.
    Karagiannis TC; Kn H; El-Osta A
    Epigenetics; 2006; 1(3):131-7. PubMed ID: 17965607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer.
    Amnekar RV; Khan SA; Rashid M; Khade B; Thorat R; Gera P; Shrikhande SV; Smoot DT; Ashktorab H; Gupta S
    World J Gastroenterol; 2020 Feb; 26(6):598-613. PubMed ID: 32103870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated valproate treatment facilitates fear extinction under specific stimulus conditions.
    Heinrichs SC; Leite-Morris KA; Rasmusson AM; Kaplan GB
    Neurosci Lett; 2013 Sep; 552():108-13. PubMed ID: 23916657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.